» Articles » PMID: 8969867

Vascular Dementia: a Construct in Evolution

Overview
Date 1996 Jan 1
PMID 8969867
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Since the late 1800s, when Alzheimer and Binswanger proposed the concept of "arteriosclerotic brain degeneration," there has been an evolution in thinking regarding cerebrovascular disease (CVD) as a basis for dementia. While later work recognized the importance of specific infarct characteristics including volume, multiplicity, and location, recent studies have found that many factors may work in combination with those characteristics to produce dementia, including white matter disease; vascular risk factors such as diabetes; comorbid illnesses, particularly those that might produce cerebral ischemia or hypoxia; genetic factors; and host characteristics such as older age and fewer years of education. Studies of the prevalence of vascular dementia (VaD) have suggested that CVD is second only to Alzheimer's disease as a basis for dementia in Western countries and the most common basis in certain Asian countries, but those studies may have underestimated the frequency of dementia associated with CVD due to a failure to perform brain imaging and decreased survival among patients with CVD. Few studies of the incidence of VaD have been performed, but they have also consistently demonstrated an elevated risk associated with CVD. While certain methodologic issues have contributed to the debate regarding the importance of CVD as a basis for dementia, including variability in the techniques that have been used to characterize brain lesions, assess cognitive function, and diagnose dementia; difficulties inherent in the determination of a causal role for CVD in dementia; and the potential confounding effects of aphasia and depression in patients with stroke, it is clear that VaD remains an important public health problem.

Citing Articles

The cog-4 subset of the national institutes of health stroke scale as a measure of cognition: relationship with baseline factors and functional outcome after stroke using data from the virtual international stroke trials archive.

Ankolekar S, Renton C, Sprigg N, Bath P Stroke Res Treat. 2013; 2013:562506.

PMID: 23589782 PMC: 3622404. DOI: 10.1155/2013/562506.


Modeling the dementia epidemic.

Treves T, Korczyn A CNS Neurosci Ther. 2011; 18(2):175-81.

PMID: 22070738 PMC: 6493479. DOI: 10.1111/j.1755-5949.2011.00242.x.


Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Chitravas N, Jung R, Kofskey D, Blevins J, Gambetti P, Leigh R Ann Neurol. 2011; 70(3):437-44.

PMID: 21674591 PMC: 3170496. DOI: 10.1002/ana.22454.


Strategies for molecular imaging dementia and neurodegenerative diseases.

Schaller B Neuropsychiatr Dis Treat. 2008; 4(3):585-612.

PMID: 18830391 PMC: 2526366. DOI: 10.2147/ndt.s2154.


Poststroke dementia in the elderly.

Mackowiak-Cordoliani M, Bombois S, Memin A, Henon H, Pasquier F Drugs Aging. 2005; 22(6):483-93.

PMID: 15974639 DOI: 10.2165/00002512-200522060-00003.